Search Results - "Damman, J"

Refine Results
  1. 1

    Mechanisms Linking the Gut Microbiome and Glucose Metabolism by Utzschneider, Kristina M, Kratz, Mario, Damman, Chris J, Hullarg, Meredith

    “…Context: Type 2 diabetes mellitus is associated with gastrointestinal dysbiosis involving both compositional and functional changes in the gut microbiome…”
    Get full text
    Journal Article
  2. 2

    Clinical and histopathological characterization of paradoxical head and neck erythema in patients with atopic dermatitis treated with dupilumab: a case series by Wijs, L.E.M., Nguyen, N.T., Kunkeler, A.C.M., Nijsten, T., Damman, J., Hijnen, D.J.

    Published in British journal of dermatology (1951) (01-10-2020)
    “…Summary Dupilumab is the first biologic registered for the treatment of atopic dermatitis (AD). We report on seven patients with AD presenting with a…”
    Get full text
    Journal Article
  3. 3

    Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease by Suskind, David L, Brittnacher, Mitchell J, Wahbeh, Ghassan, Shaffer, Michele L, Hayden, Hillary S, Qin, Xuan, Singh, Namita, Damman, Christopher J, Hager, Kyle R, Nielson, Heather, Miller, Samuel I

    Published in Inflammatory bowel diseases (01-03-2015)
    “…Crohn's disease (CD) is a chronic idiopathic inflammatory intestinal disorder associated with fecal dysbiosis. Fecal microbial transplant (FMT) is a potential…”
    Get full text
    Journal Article
  4. 4

    The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions by Vindigni, Stephen M., Zisman, Timothy L., Suskind, David L., Damman, Christopher J.

    Published in Therapeutic Advances in Gastroenterology (01-07-2016)
    “…We discuss the tripartite pathophysiological circuit of inflammatory bowel disease (IBD), involving the intestinal microbiota, barrier function, and immune…”
    Get full text
    Book Review Journal Article
  5. 5

    Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis by Damman, J. L., Rodriguez, E. A., Ali, A. H., Buness, C. W., Cox, K. L., Carey, E. J., Lindor, K. D.

    Published in Alimentary pharmacology & therapeutics (01-04-2018)
    “…Summary Background and Aims PSC is an autoimmune biliary inflammatory disorder that is often associated with inflammatory bowel disease (IBD), with 50%‐75% of…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Complement activation in Hidradenitis suppurativa: Covert low-grade inflammation or innocent bystander? by van Straalen, K. R., Dudink, K., Aarts, P., van der Zee, H. H., van den Bosch, T. P. P., Giang, J., Prens, E. P., Damman, J.

    Published in Frontiers in immunology (21-09-2022)
    “…Hidradenitis suppurativa (HS) is a chronic auto-inflammatory skin disease with a complex and multifactorial pathogenesis involving both the innate and adaptive…”
    Get full text
    Journal Article
  8. 8

    Low Level Engraftment and Improvement following a Single Colonoscopic Administration of Fecal Microbiota to Patients with Ulcerative Colitis by Damman, Christopher J, Brittnacher, Mitchell J, Westerhoff, Maria, Hayden, Hillary S, Radey, Matthew, Hager, Kyle R, Marquis, Sara R, Miller, Samuel I, Zisman, Timothy L

    Published in PloS one (19-08-2015)
    “…Fecal microbiota transplantation (FMT) is an investigational treatment for diseases thought to involve alterations in the intestinal microbiota including…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    New insight into the effects of heparinoids on complement inhibition by C1‐inhibitor by Poppelaars, F., Damman, J., de Vrij, E. L., Burgerhof, J. G. M., Saye, J., Daha, M. R., Leuvenink, H. G., Uknis, M. E., Seelen, M. A. J.

    Published in Clinical and experimental immunology (01-06-2016)
    “…Summary Complement activation is of major importance in numerous pathological conditions. Therefore, targeted complement inhibition is a promising therapeutic…”
    Get full text
    Journal Article
  12. 12

    Effect of TREM-1 blockade and single nucleotide variants in experimental renal injury and kidney transplantation by Tammaro, A., Kers, J., Emal, D., Stroo, I., Teske, G. J. D., Butter, L. M., Claessen, N., Damman, J., Derive, M., Navis, G., Florquin, S., Leemans, J. C., Dessing, M. C.

    Published in Scientific reports (08-12-2016)
    “…Renal ischemia reperfusion (IR)-injury induces activation of innate immune response which sustains renal injury and contributes to the development of delayed…”
    Get full text
    Journal Article
  13. 13

    GUTSS: An Alignment-Free Sequence Comparison Method for Use in Human Intestinal Microbiome and Fecal Microbiota Transplantation Analysis by Brittnacher, Mitchell J, Heltshe, Sonya L, Hayden, Hillary S, Radey, Matthew C, Weiss, Eli J, Damman, Christopher J, Zisman, Timothy L, Suskind, David L, Miller, Samuel I

    Published in PloS one (08-07-2016)
    “…Comparative analysis of gut microbiomes in clinical studies of human diseases typically rely on identification and quantification of species or genes. In…”
    Get full text
    Journal Article
  14. 14

    Complement Mediated Renal Inflammation Induced by Donor Brain Death: Role of Renal C5a‐C5aR Interaction by van Werkhoven, M. B., Damman, J., van Dijk, M. C. R. F., Daha, M. R., de Jong, I. J., Leliveld, A., Krikke, C., Leuvenink, H. G., van Goor, H., van Son, W. J., Olinga, P., Hillebrands, J.‐L., Seelen, M. A. J.

    Published in American journal of transplantation (01-04-2013)
    “…Kidneys retrieved from brain‐dead donors have impaired allograft function after transplantation compared to kidneys from living donors. Donor brain death (BD)…”
    Get full text
    Journal Article
  15. 15

    Perspective: Nutrition’s Next Chapter – Bioactive Gaps and the Microbiome–Mitochondria Axis by Damman, Christopher J.

    Published in Advances in nutrition (Bethesda, Md.) (01-05-2023)
    “…Food has the power to heal. Our bodies transform and are transformed by the elements in food, and the adage that we are what we eat is true. The twentieth…”
    Get full text
    Journal Article
  16. 16

    Conversion from tacrolimus to everolimus with complete and early glucocorticoid withdrawal after kidney transplantation: a randomised trial by Bouamar, R, Shuker, N, Osinga, J A J, Clahsen-van Groningen, M C, Damman, J, Baan, C C, van de Wetering, J, Rowshani, A T, Kal-van Gestel, J, Weimar, W, van Gelder, T, Hesselink, D A

    Published in Netherlands journal of medicine (01-01-2018)
    “…While conversion from cyclosporine to everolimus is well documented, conversion from tacrolimus has been poorly studied. In this randomised, controlled trial…”
    Get full text
    Journal Article
  17. 17
  18. 18

    The Microbiome and Inflammatory Bowel Disease: Is There a Therapeutic Role for Fecal Microbiota Transplantation? by DAMMAN, Christopher J, MILLER, Samuel I, SURAWICZ, Christina M, ZISMAN, Timothy L

    Published in The American journal of gastroenterology (01-10-2012)
    “…One hypothesis for the etiology of inflammatory bowel disease is that an altered or pathogenic microbiota causes inflammation in a genetically susceptible…”
    Get full text
    Journal Article
  19. 19

    Patients Perceive Clinical Benefit with the Specific Carbohydrate Diet for Inflammatory Bowel Disease by Suskind, David L., Wahbeh, Ghassan, Cohen, Stanley A., Damman, Christopher J., Klein, Jani, Braly, Kim, Shaffer, Michele, Lee, Dale

    Published in Digestive diseases and sciences (01-11-2016)
    “…Background Recent studies suggest that dietary therapy may be effective for patients with inflammatory bowel disease (IBD), but limited published data exist on…”
    Get full text
    Journal Article
  20. 20

    Kidney Injury Molecule‐1 is an Early Noninvasive Indicator for Donor Brain Death‐Induced Injury Prior to Kidney Transplantation by Nijboer, W. N., Schuurs, T. A., Damman, J., Van Goor, H., Vaidya, V. S., Van Der Heide, J. J. Homan, Leuvenink, H. G. D., Bonventre, J. V., Ploeg, R. J.

    Published in American journal of transplantation (01-08-2009)
    “…With more marginal deceased donors affecting graft viability, there is a need for specific parameters to assess kidney graft quality at the time of organ…”
    Get full text
    Journal Article